Bacterial biocontrol for Zika virus
The Eliminate Dengue Program is developing a natural method for controlling mosquito-transmitted diseases such as dengue and chikungunya. Now, the program’s Brazilian project team is using the method to control the spread of Zika virus (ZIKV).
Led by Dr Luciano Moreira (FIOCRUZ — Centro de Pesquisas René Rachou), the researchers are infecting mosquitoes with naturally occurring bacteria, called Wolbachia, that reduce the ability of the mosquitoes to transmit the disease-causing virus to humans. Wolbachia occurs naturally in up to 60% of all insect species and is passed to new generations during reproduction.
“One of the most important features of our project is how sustainable it is,” noted Dr Moreira. “After we release Wolbachia-infected mosquitoes into an area over the period of a few months, they increase and maintain their prevalence naturally without us having to continually release more mosquitoes.”
Dr Moreira’s team uses ZEN Double-Quenched Probes from Integrated DNA Technologies (IDT) to monitor the persistence of viruses within the mosquito population. Their recent research shows that by dispersing Wolbachia-infected mosquitoes, they can significantly reduce risk of transmission of ZIKV and dengue virus. Now IDT is donating reagents to Eliminate Dengue Brazil so that additional research can be completed quickly and efficiently.
“IDT is committed to sponsoring innovative research that drives medical, agricultural and environmental advances,” said IDT founder and CEO Dr Joseph A Walder. “We are proud to be able to support the work being done by Eliminate Dengue Brazil to reduce Zika virus transmission. This is an important global issue being addressed using a natural, sustainable and safe method.”
$96m RNA Research and Manufacturing Facility opens in NSW
The new 4500 sqm RNA Research and Manufacturing Facility within the Macquarie University...
Cartherics and Catalent announce enhanced partnership
To support immune cell therapy products for the treatment of cancer and endometriosis, Australian...
Alliance seeks to boost regional capacity in clinical trials
Launched this week, the Barwon Health–Deakin University Clinical Trials Alliance is...
